Verified Supplier
Biocytogen Jiangsu Gene Biotechnology Co., Ltd.Biocytogen Jiangsu Gene Biotechnology Co...
竞
Registry
| Main | TCR-like antibody technology, combined with traditional immunization methods and high-throughput antibody screening approaches, not only enables efficient acquisition of fully human antibody sequences but also ensures that the obtained sequences have undergone in vivo affinity maturation. |
|---|
Contact
Contact
Sign in to view full contact info Sign in
Profile
Antibody Drugs - Biocytogen - Stable Efficacy TCR-like antibody technology combines traditional immunization methods with high-throughput antibody screening, which not only efficiently obtains fully human antibody sequences but also ensures that the obtained sequences have undergone in vivo affinity maturation.
ProductsAll →
Company Products Total 0 items
📦
No products yet
* Company business data is collected and compiled from public sources